현대약품
004310KOSPI의약품 제조업41.1 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Hyundai Pharm focuses on the production and sale of prescription and OTC pharmaceuticals, food, cosmetics, and medical devices, supplying products such as hypertension medication Tenolmin, hair loss treatment Minoxil, and dietary fiber beverage Mieyro Haiiba both domestically and internationally. The company has established a competitive edge in the functional cosmetics market through its brand Labcle, which emphasizes eco-friendly ingredients and sustainable packaging, aligning with global green consumption trends.
Number of Employees
399people
Average Salary
71.7M KRW
Score Calculation Basis
Detailed Financial Score
5.1x industry avg (risky)
2.5x industry avg (risky)
Below industry avg
In line with industry avg
Avg ▲3.2% (2-year basis)
Avg ▲1051.5% (2-year basis)
Avg ROE 3.2% (declining, 3yr)
Detailed News Sentiment
- Positive디엑스앤브이엑스 "전문인력 영입…R&D 강화"
현대약품의 자회사 디엑스앤브이엑스가 핵심 연구 인력을 영입하여 R&D 역량을 강화함으로써 미래 성장 가능성이 높아졌다.
- Neutral11번가, 소비자 위한 ‘할인 정책’ 내놓는 이유[마켓인사이트]
11번가의 할인 정책은 소비자 유치를 위한 전략으로, 현대약품과 직접적인 연관성이 없다.
- Neutral11번가, ‘T 멤버십’ 무제한 최대 5000원 할인
11번가의 T 멤버십 할인 행사는 현대약품과 직접적인 연관성이 없어 중립적인 영향을 미친다.
Detailed Momentum
52w lower range (21%)
1m -27.50% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral기업지배구조보고서공시2026-06-01
